Ignite Creation Date:
2025-12-25 @ 12:58 AM
Ignite Modification Date:
2026-07-01 @ 8:57 PM
Study NCT ID:
NCT04636593
Status:
UNKNOWN
Last Update Posted:
2021-01-12
First Post:
2020-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC
Sponsor:
First People's Hospital of Hangzhou
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AlmonTRT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |